Obagi Medical Products Introduces Blue Peel RADIANCE and Nu-Derm Sun Shield SPF 50

Obagi Medical Products, Inc. (Nasdaq:OMPI), a leader in topical aesthetic and therapeutic skin health systems and creator of the original Blue Peel®, announces the availability of Obagi Blue Peel RADIANCE, an easy-to-use peel that provides instant glowing results for all skin types with little downtime, and Nu-Derm Sun Shield SPF 50, an elegant line extension to Obagi Medical’s top-selling, Nu-Derm product line.

“The original Blue Peel is one of the most effective professional peels on the market, but is not appropriate for many patients in many situations. Blue Peel RADIANCE provides our physician accounts a flexible, easy-to-use option that can be used successfully on nearly all skin types,” Jim Hartman, Vice President of Global Marketing and Business Development at Obagi Medical, said. “As for the new sunscreen, we believe sun protection is the most important component of any skin health regimen, but many consumers still do not use sunscreen every day. This new line extension provides a high level of sun protection in an elegant, sheer formula that can be used daily by patients with nearly any skin type with or without makeup.”

A salicylic acid-based peel, Blue Peel RADIANCE utilizes a unique blend of acids and other soothing ingredients for a potent combination that exfoliates, evens out skin tone and improves overall complexion, with little-to-no downtime. Skin may be tighter, smoother and brighter-looking after just one application. In a recent clinical assessment, 92 percent of patients saw an improvement in their skin texture after just one peel.1 Blue Peel RADIANCE is a professional product for in-office procedures only and will be sold exclusively to professionals.

Nu-Derm Sun Shield SPF 50 combines UVB absorption and UVA blockage for high sunscreen protection in and elegant, matte finish that can be used on nearly all skin types. Nu-Derm Sun Shield SPF 50 features the active ingredients Zinc Oxide (10.5%) and Octinoxate (7.5%).

About Obagi Medical Products, Inc.

Obagi Medical Products is a specialty pharmaceutical company that develops, markets and sells, and is a leading provider of, proprietary topical aesthetic and therapeutic prescription-strength skin care systems in the physician-dispensed market. Using its Penetrating Therapeutics™ technologies, Obagi Medical’s products are designed to improve penetration of agents across the skin barrier for common and visible skin conditions in adult skin including premature aging, photodamage, hyperpigmentation (irregular or patchy discoloration of the skin), acne, sun damage, rosacea, and soft tissue deficits, such as fine lines and wrinkles. The history of Obagi’s skin care product introductions is as follows: Obagi Nu-Derm®, Obagi-C® Rx (the first and only prescription-strength vitamin C and hydroquinone system), Obagi® Professional-C (a line of highly stable vitamin C serums), Obagi Condition & Enhance® for use with cosmetic procedures to enhance patient outcomes and satisfaction, Obagi ELASTIderm® Eye Treatment and Obagi CLENZIderm® M.D. acne therapeutic systems, a formulation of Obagi CLENZIderm M.D. Systems for normal to dry skin, and Obagi ELASTIderm Décolletage System, Obagi Rosaclear® System, and Obagi ELASTILash™ Eyelash Solution. Visit www.obagi.com for information.

Blue Peel RADIANCE, ELASTILash and Penetrating Therapeutics are trademarks, and Obagi, Blue Peel, Condition & Enhance, ELASTIderm, Nu-Derm, Obagi-C, Obagi CLENZIderm and Rosaclear are registered trademarks, of Obagi Medical Products, Inc. and/or its affiliates in the United States and certain other countries.

1 OMP, Inc. Data on file.

Obagi Medical Products, Inc. (MM) (NASDAQ:OMPI)
Historical Stock Chart
From Oct 2024 to Nov 2024